Dirk Smith is the Founder and Principal of Insight BioConsulting, based in the Seattle area. He provides independent consulting to academic and industry clients, including strategic guidance and assistance advancing therapeutic programs and new technology. Dirk was previously in the Inflammation Research group at Amgen’s Seattle campus where he led biologics programs from early discovery to clinical testing and published regularly in the areas of cytokine biology and immunology. Dirk was also in charge of research-stage biomarker development for Amgen’s asthma pipeline and led collaborative programs with deCODE Genetics.
Prior to joining industry, Dirk was at Fred Hutchinson Cancer Research Center, where he contributed to oncology research teams investigating tumor resistance and growth regulation. Dirk received his BSc. From Washington State University and his MSc. in Genetics from the University of New Hampshire.